BioMarin to Buy Amicus Therapeutics for $4.8 Billion
WSJ·2025-12-19 13:13Group 1 - BioMarin Pharmaceutical has agreed to acquire Amicus Therapeutics for approximately $4.8 billion in cash [1]
WSJ·2025-12-19 13:13 WSJ·2025-12-19 13:13 WSJ·2025-12-19 13:13Group 1 - BioMarin Pharmaceutical has agreed to acquire Amicus Therapeutics for approximately $4.8 billion in cash [1]